Role of gap junction intercellular communication in testicular leydig cell apoptosis induced by oxaliplatin via the mitochondrial pathway

Oncology Reports

Volumn 33, Issue 1, 2015, Pages 207-214

  Tong, Xuhui ^a   Han, Xi ^a   Yu, Binbin ^a   Yu, Meiling ^a   Jiang, Guojun ^a   Ji, Jie ^a   Dong, Shuying ^a  

^a BENGBU MEDICAL COLLEGE   (China)

Author keywords

Apoptosis; Gap junction; Oxaliplatin; Testis

Indexed keywords

18ALPHA GLYCYRRHETINIC ACID; CASPASE 3; CASPASE 9; CONNEXIN 43; LIPOCORTIN 5; OLEAMIDE; OXALIPLATIN; PROTEIN BAX; PROTEIN BCL 2; RETINOIC ACID; ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; PLATINUM COMPLEX;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL COMMUNICATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; GAP JUNCTION; LEYDIG CELL; MALE; MITOCHONDRION; MOUSE; MTT ASSAY; NONHUMAN; PROTEIN EXPRESSION; WESTERN BLOTTING; ANIMAL; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL COMMUNICATION; CELL LINE, TUMOR; CELL SURVIVAL; GAP JUNCTIONS; LEYDIG CELLS; MALE; MICE; MITOCHONDRIA; ORGANOPLATINUM COMPOUNDS;

EID: 84916242400     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3571     Document Type: Article

References (40)

1. Chauvigne F, Zapater C, Gasol JM and Cerda J: Germ-line activation of the luteinizing hormone receptor directly drives spermiogenesis in a nonmammalian vertebrate. Proc Natl Acad Sci USA 111: 1427-1432, 2014.
2. Chauvigne F, Verdura S, Mazon MJ, et al: Follicle-stimulating hormone and luteinizing hormone mediate the androgenic pathway in Leydig cells of an evolutionary advanced teleost. Biol Reprod 87: 35, 2012.
3. Sakaeda T, Kadoyama K and Okuno Y: Adverse event profiles of platinum agents: data mining of the public version of the FDA adverse event reporting system, AERS, and reproducibility of clinical observations. Int J Med Sci 8: 487-491, 2011.
4. Martelli L, Ragazzi E, Di Mario F, Basato M and Martelli M: Cisplatin and oxaliplatin cytotoxic effects in sensitive and cisplatin-resistant human cervical tumor cells: time and mode of application dependency. Anticancer Res 29: 3931-3937, 2009.
5. Perry J, Powles T, Shamash J, et al: The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines. Cancer Chemother Pharmacol 64: 925-933, 2009.
6. Stordal BK, Davey MW and Davey RA: Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells. Cancer Chemother Pharmacol 58: 256-265, 2006.
7. Stordal B, Pavlakis N and Davey R: Oxaliplatin for the treatment of cisplatin-resistant cancer: a systematic review. Cancer Treat Rev 33: 347-357, 2007.
8. Tozawa K, Oshima T, Kobayashi T, et al: Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer. Anticancer Res 28: 2087-2092, 2008.
9. Montopoli M, Ragazzi E, Froldi G and Caparrotta L: Cell-cycle inhibition and apoptosis induced by curcumin and cisplatin or oxaliplatin in human ovarian carcinoma cells. Cell Prolif 42: 195-206, 2009.
10. Su V and Lau AF: Connexins: mechanisms regulating protein levels and intercellular communication. FEBS Lett 588: 1212-1220, 2014.
11. Kjenseth A, Fykerud T, Rivedal E and Leithe E: Regulation of gap junction intercellular communication by the ubiquitin system. Cell Signal 22: 1267-1273, 2010.
12. Kahiri CN, Khalil MW, Tekpetey F and Kidder GM: Leydig cell function in mice lacking connexin43. Reproduction 132: 607-616, 2006.
13. Gunther S, Fietz D, Weider K, Bergmann M and Brehm R: Effects of a murine germ cell-specific knockout of Connexin 43 on Connexin expression in testis and fertility. Transgenic Res 22: 631-641, 2013.
14. Giese S, Hossain H, Markmann M, et al: Sertoli-cell-specific knockout of connexin 43 leads to multiple alterations in testicular gene expression in prepubertal mice. Dis Model Mech 5: 895-913, 2012.
15. Sato T, Neschadim A, Lavie A, Yanagisawa T and Medin JA: The engineered thymidylate kinase (TMPK)/AZT enzyme-prodrug axis offers efficient bystander cell killing for suicide gene therapy of cancer. PLoS One 8: e78711, 2013.
16. Tong X, Dong S, Yu M, Wang Q and Tao L: Role of heteromeric gap junctions in the cytotoxicity of cisplatin. Toxicology 310: 53-60, 2013.
17. Autsavapromporn N, De Toledo SM, Jay-Gerin JP, Harris AL and Azzam EI: Human cell responses to ionizing radiation are differentially affected by the expressed connexins. J Radiat Res 54: 251-259, 2013.
18. Ohshima Y, Tsukimoto M, Harada H and Kojima S: Involvement of connexin43 hemichannel in ATP release after gamma-irradiation. J Radiat Res 53: 551-557, 2012.
19. Mancuso M, Pasquali E, Leonardi S, et al: Role of connexin43 and ATP in long-range bystander radiation damage and oncogenesis in vivo. Oncogene 30: 4601-4608, 2011.
20. Colombo BM, Benedetti S, Ottolenghi S, et al: The 'bystander effect': association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Hum Gene Ther 6: 763-772, 1995.
21. Hutnik CM, Pocrnich CE, Liu H, Laird DW and Shao Q: The protective effect of functional connexin43 channels on a human epithelial cell line exposed to oxidative stress. Invest Ophthalmol Vis Sci 49: 800-806, 2008.
22. Lin D and Takemoto DJ: Oxidative activation of protein kinase Cgamma through the C1 domain. Effects on gap junctions. J Biol Chem 280: 13682-13693, 2005.
23. Kozoriz MG, Bechberger JF, Bechberger GR, et al: The connexin43 C-terminal region mediates neuroprotection during stroke. J Neuropathol Exp Neurol 69: 196-206, 2010.
24. Giardina SF, Mikami M, Goubaeva F and Yang J: Connexin 43 confers resistance to hydrogen peroxide-mediated apoptosis. Biochem Biophys Res Commun 362: 747-752, 2007.
25. Farahani R, Pina-Benabou MH, Kyrozis A, et al: Alterations in metabolism and gap junction expression may determine the role of astrocytes as 'good samaritans' or executioners. Glia 50: 351-361, 2005.
26. Hong X, Wang Q, Yang Y, et al: Gap junctions propagate opposite effects in normal and tumor testicular cells in response to cisplatin. Cancer Lett 317: 165-171, 2012.
27. Koreen IV, Elsayed WA, Liu YJ and Harris AL: Tetracyclineregulated expression enables purification and functional analysis of recombinant connexin channels from mammalian cells. Biochem J 383: 111-119, 2004.
28. Tao L and Harris AL: 2-aminoethoxydiphenyl borate directly inhibits channels composed of connexin26 and/or connexin32. Mol Pharmacol 71: 570-579, 2007.
29. Wu J, Taylor RN and Sidell N: Retinoic acid regulates gap junction intercellular communication in human endometrial stromal cells through modulation of the phosphorylation status of connexin 43. J Cell Physiol 228: 903-910, 2013.
30. Kim SJ, Park EY, Hwang TK and Kim JC: Therapeutic effects of connexin inhibitors on detrusor overactivity induced by bladder outlet obstruction in rats. Urology 78: 475.e471-477, 2011.
31. Chater S, Amara S, Moussata D, et al: Differential effects of ionizing radiation and platinum-derivative chemotherapy on apoptotic pathways in testicular germ cells. Int J Radiat Biol 83: 269-278, 2007.
32. Bowden NA: Nucleotide excision repair: why is it not used to predict response to platinum-based chemotherapy? Cancer Lett 346: 163-171, 2014.
33. Bonetti A, Giuliani J and Muggia F: Targeted agents and oxaliplatin-containing regimens for the treatment of colon cancer. Anticancer Res 34: 423-434, 2014.
34. Hayward RL, Macpherson JS, Cummings J, Monia BP, Smyth JF and Jodrell DI: Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: genetic evidence for specificity of the antisense effect. Mol Cancer Ther 3: 169-178, 2004.
35. Gourdier I, Crabbe L, Andreau K, Pau B and Kroemer G: Oxaliplatin-induced mitochondrial apoptotic response of colon carcinoma cells does not require nuclear DNA. Oncogene 23: 7449-7457, 2004.
36. Gaete PS, Lillo MA and Figueroa XF: Functional role of connexins and pannexins in the interaction between vascular and nervous system. J Cell Physiol 229: 1336-1345, 2014.
37. Carette D, Gilleron J, Chevallier D, Segretain D and Pointis G: Connexin a check-point component of cell apoptosis in normal and physiopathological conditions. Biochimie 101: 1-9, 2013.
38. Decrock E, Krysko DV, Vinken M, et al: Transfer of IP3 through gap junctions is critical, but not sufficient, for the spread of apoptosis. Cell Death Differ 19: 947-957, 2012.
39. Kameritsch P, Khandoga N, Pohl U and Pogoda K: Gap junctional communication promotes apoptosis in a connexintype-dependent manner. Cell Death Dis 4: e584, 2013.
40. Swanton E, Savory P, Cosulich S, Clarke P and Woodman P: Bcl-2 regulates a caspase-3/caspase-2 apoptotic cascade in cytosolic extracts. Oncogene 18: 1781-1787, 1999.